The Company and Significant Accounting Policies - (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of Countries in which Pharmaceutical is Approved	47
Number of Countries within the European Union in which Pharmaceutical is Approved	28
Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of customers that counted for more than 10% of accounts receivable	4	4
Customer Concentration Risk [Member] | Customer One [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer percentage of accounts receivable	22.00%	25.00%
Customer Concentration Risk [Member] | Customer Two [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer percentage of accounts receivable	20.00%	22.00%
Customer Concentration Risk [Member] | Customer Three [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer percentage of accounts receivable	19.00%	19.00%
Customer Concentration Risk [Member] | Customer Four [Member] | Accounts Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer percentage of accounts receivable	18.00%	15.00%